Broad spectrum matrix metalloproteinase inhibitors: An examination of succinamide hydroxamate inhibitors with P1 Cα gem-disubstitution
- 1 June 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (12) , 1443-1448
- https://doi.org/10.1016/s0960-894x(98)00255-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inhibition of Stromelysin-1 (MMP-3) by P1‘-Biphenylylethyl Carboxyalkyl DipeptidesJournal of Medicinal Chemistry, 1997
- Emerging Therapeutic Advances for the Development of Second Generation Matrix Metalloproteinase InhibitorsCurrent Pharmaceutical Design, 1997
- Inhibition of Matrix Metalloproteinases: Structure Based DesignCurrent Pharmaceutical Design, 1996
- Inhibitors of MMP-1: an examination of P1′ Cα gem-disubstitution in the succinamide hydroxamate seriesBioorganic & Medicinal Chemistry Letters, 1996
- Matrix metal loproteinases and the development of cancerChemistry & Biology, 1996
- Rapid quantitative determination of a collagenase inhibitor and its major metabolite by on-line liquid chromatography with ionspray tandem mass spectrometric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1995
- Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzymeProtein Science, 1995
- Matrix Metalloproteinases: A ReviewCritical Reviews in Oral Biology & Medicine, 1993
- A Short Diastereoselective Synthesis of 2,3-Disubstituted SuccinatesSynlett, 1993